Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic-phase chronic myeloid leukemia.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Zeev Estrov Elias J Jabbour Jorge Eduardo Cortes Gautam Borthakur Jan A Burger Shilpa Paul Prithviraj Bose Kiran Naqvi Hagop Kantarjian Musa Yilmaz Naveen Pemmaraju Jeff Skinner Koichi Takahashi |
| Publication date | May 3, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |